{
    "nctId": "NCT04202848",
    "briefTitle": "The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients",
    "officialTitle": "The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients",
    "overallStatus": "UNKNOWN",
    "conditions": "Lung Cancer, Breast Cancer, Gastrointestinal Cancer, Malignant Neoplasms",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 500,
    "primaryOutcomeMeasure": "The change of diversity of intestinal flora in faeces during therapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age 18-85 years old, male or female\n2. Clinical diagnosis of malignant tumors\n3. It is planned to receive cancer treatment\n4. The genre of therapies is not limited, which contain chemotherapy, radiation therapy, immune targeted, endocrine therapy, surgery, traditional Chinese medicine and other modern therapies\n\nExclusion Criteria:\n\n1. Cancer treatment before therapies\n2. Previous history: He has suffered from intestinal microecology-related diseases such as cirrhosis, ulcerative colitis, Crohn's disease, irritable bowel syndrome, and urinary system diseases\n3. Neurological, psychiatric or unconscious disorders.\n4. The following drugs were used within 2 weeks before enrollment:\n\n   1. Probiotic preparations, various prebiotic preparations, etc\n   2. gastrointestinal peristaltic drug;\n   3. Take drugs known to have a significant effect on the intestinal and urethral flora within half a year (such as proton pump inhibitors, purgatives, bismuth, adsorbents, non-steroidal anti-inflammatory drugs, etc.)\n5. Other situations that the researcher considers unsuitable to participate in the experiment;",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}